跳至主要内容
临床试验/NCT06247254
NCT06247254
进行中(未招募)
不适用

Telehealth-Enhanced Assessment and Management After Stroke-Blood Pressure (TEAMS-BP)

Wake Forest University Health Sciences1 个研究点 分布在 1 个国家目标入组 86 人2024年11月15日

概览

阶段
不适用
干预措施
Intensive Tailored Telehealth Management
疾病 / 适应症
Blood Pressure
发起方
Wake Forest University Health Sciences
入组人数
86
试验地点
1
主要终点
Attaining the Target Systolic Blood Pressure of <130 mmHg
状态
进行中(未招募)
最后更新
19天前

概览

简要总结

TEAMS-BP is a Patient-Centered Outcomes Research Institute (PCORI)-funded trial under the Phased Large Awards for Comparative Effectiveness Research (PLACER) funding mechanism to evaluate two comprehensive and evidence-based strategies for managing blood pressure (BP) following stroke.

详细描述

Hypertension affects nearly half of the US population (46% of adults) and is the strongest risk factor for recurrent stroke. Prevalence in patients with ischemic or hemorrhagic stroke in the US varies by region (highest in the South) ranging from 70% to 82%, and is associated with greater risk of recurrent stroke, major cardiovascular events, and death. A vital question for stroke patients and caregivers is how to prevent a recurrent stroke and further adverse events. Multiple clinical trials have shown that lowering BP reduces the risk for cardiovascular disease and stroke. Few trials, however, included stroke patients with a focus on secondary prevention nor were representative of vulnerable populations. The former US Surgeon General recently published a Call to Action focused on BP with three goals: 1) make hypertension control a national priority; 2) ensure that communities support hypertension control; and 3) optimize patient care for hypertension control.

注册库
clinicaltrials.gov
开始日期
2024年11月15日
结束日期
2028年7月1日
最后更新
19天前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

入排标准

入选标准

  • Diagnosis of ischemic stroke defined as acute brain, spinal cord, or retinal infarction based on objective evidence on imaging (such as a focal area of restricted diffusion on Magnetic Resonance Imaging \[MRI\]) in a defined vascular distribution or clinical evidence of focal ischemic injury based on symptoms persisting \> 24 hours; or spontaneous hemorrhagic stroke defined as a focal collection of blood within the brain parenchyma that is non-traumatic and identified by brain computed tomography (CT) or brain MRI
  • Age ≥18 years
  • Discharged directly home from acute care or inpatient rehabilitation
  • At least one of the following: documented history of hypertension; self-reported history of hypertension; use of
  • hypertension medications (either prescribed prior to stroke, administered during hospital stay, or prescribed at discharge)
  • Systolic Blood Pressure ≥ 130 mmHg
  • Able to read and understand English or Spanish,
  • Have access to a functioning smartphone or tablet with cellular connectivity
  • Willing to install and use a study-compatible physical activity monitoring application on their smartphone or tablet or smartphone or tablet of a qualifying caregiver
  • Stated agreement to participate in either intervention to which they are assigned and attend all required study visits,

排除标准

  • Subdural hematoma or subarachnoid hemorrhage
  • Current participation in another stroke clinical trial precluding dual enrollment
  • Presence of terminal illness, such as cancer, that limits life expectancy to \<1 year
  • Diagnosis of end-stage renal disease defined as permanent kidney dysfunction requiring the use of hemodialysis or peritoneal dialysis
  • Pregnancy, lactation or planning to become pregnant
  • Late-stage Alzheimer's disease or related dementia
  • Transitioned to a facility such as skilled nursing or long-term care prior to enrollment
  • Mid upper arm circumference \> 45 cm/17.7 inches or \< 22 cm / 8.66 inches
  • Missing values for Systolic Blood Pressure or Patient Activation Measure (PAM) score at baseline
  • Any condition that in the opinion of the study investigator would preclude the participant from being able to safely participate in the trial

研究组 & 干预措施

Intensive Tailored Telehealth Management (ITTM)

ITTM is a novel adaptation of the Home Blood Pressure Telemonitoring and Case Management to Control Hypertension (HyperLink) model, based on the premise that patients have social and functional barriers to blood pressure management. In the ITTM arm, barriers to care are identified and addressed through Blood Pressure Care Plan messaging and referrals to needed resources. The ITTM intervention includes a tailored Blood Pressure Care Plan and health coaching contracted through INTERVENT. INTERVENT services may be reimbursed using Chronic Care Management (CCM) and Remote Patient Monitoring (RPM) insurance billing codes. Blood pressure monitors and wearable physical activity trackers will be provided to participants as part of the study.

干预措施: Intensive Tailored Telehealth Management

Intensive Clinic Management (ICM)

ICM is based on the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) model and includes blood pressure management at in-person follow-up visits occurring every 2 months when systolic blood pressures are at target (i.e., \< 130 mmHg), and monthly when systolic blood pressure is ≥ 130 mmHg. Participants will also receive low-touch health promotion messaging via text messaging, with reminders focused on medication adherence, healthy diet, and physical activity and a tailored Blood Pressure Care Plan for managing stroke recovery. Participants will be encouraged to monitor their blood pressure at home and record values in logs. Blood pressure monitors will be provided as part of the study.

干预措施: Intensive Clinic Management

结局指标

主要结局

Attaining the Target Systolic Blood Pressure of <130 mmHg

时间窗: Month 6

Systolic blood pressure will be calculated as the average of the second and third of 3 successive measures by the research coordinator according to standard protocols at 6 months (Study Visit 3).

次要结局

  • Change in Systolic Blood Pressure (SBP) at from baseline to 6 months post-stroke(Baseline to Month 6)
  • Number of major adverse cardiovascular events (MACE)(Month 12)
  • Change in Patient Activation Measured with the Patient Activation Measure (PAM)(Month 6)

研究点 (1)

Loading locations...

相似试验